Varaico: Literature-Extracted Genetic Variants

Gene:PCDH19
Variant:p.N557K
Back to variants list

PCDH19

NM_001184880.2:p.N557K

Associated Papers

Evaluating genome sequencing strategies: trio, singleton, and standard testing in rare disease diagnosis.

Kaschta D et al.

Genome Medicine, 2025

40963120 (PubMed )
Supplement: 13073_2025_1516_MOESM1_ESM.xlsx › S1_Cohort

Multicenter retrospective study of patients with PCDH19-related epilepsy: The first Hungarian cohort.

Kovacs M et al.

Epileptic Disorders : International Epilepsy Journal With Videotape, 2024

Multiomic analysis implicates nuclear hormone receptor signalling in clustering epilepsy.

de Nys R et al.

Translational Psychiatry, 2024

38280856 (PubMed )
Supplement: 41398_2024_2783_MOESM2_ESM.xlsx › Sheet1

Integrated in silico and experimental assessment of disease relevance of PCDH19 missense variants.

Pham DH et al.

Human Mutation, 2021

Comparative characterization of PCDH19 missense and truncating variants in PCDH19-related epilepsy.

Shibata M et al.

Journal of Human Genetics, 2021

33262389 (PubMed )
Supplement: 10038_2020_880_MOESM4_ESM.xlsx › Supplemental_Table_2

A standardized patient-centered characterization of the phenotypic spectrum of PCDH19 girls clustering epilepsy.

Kolc KL et al.

Translational Psychiatry, 2020

32366910 (PubMed )
Supplement: 41398_2020_803_MOESM6_ESM.pdf

PCDH19 Pathogenic Variants in Males: Expanding the Phenotypic Spectrum.

Kolc KL et al.

Advances in Experimental Medicine and Biology, 2020

A systematic review and meta-analysis of 271 PCDH19-variant individuals identifies psychiatric comorbidities, and association of seizure onset and disease severity.

Kolc KL et al.

Molecular Psychiatry, 2019

29892053 (PubMed )
Supplement: 41380_2018_66_MOESM1_ESM.xlsx › Review

Optimizing genomic medicine in epilepsy through a gene-customized approach to missense variant interpretation.

Traynelis J et al.

Genome Research, 2017

28864458 (PubMed )
Supplement: supp_gr.226589.117_Supplemental_Data_S1.xlsx › Data_S1

Protocadherin 19 (PCDH19) interacts with paraspeckle protein NONO to co-regulate gene expression with estrogen receptor alpha (ERα).

Pham DH et al.

Human Molecular Genetics, 2017

Structural determinants of adhesion by Protocadherin-19 and implications for its role in epilepsy.

Cooper SR et al.

Elife, 2016

Mutations of protocadherin 19 in female epilepsy (PCDH19-FE) lead to allopregnanolone deficiency.

Tan C et al.

Human Molecular Genetics, 2015

Clinical and genetic aspects of PCDH19-related epilepsy syndromes and the possible role of PCDH19 mutations in males with autism spectrum disorders.

van Harssel JJ et al.

Neurogenetics, 2013

PCDH19-related infantile epileptic encephalopathy: an unusual X-linked inheritance disorder.

Depienne C et al.

Human Mutation, 2012

Spectrum of phenotypes in female patients with epilepsy due to protocadherin 19 mutations.

Specchio N et al.

Epilepsia, 2011

Protocadherin 19 mutations in girls with infantile-onset epilepsy.

Marini C et al.

Neurology, 2010

Epilepsy and mental retardation limited to females with PCDH19 mutations can present de novo or in single generation families.

Hynes K et al.

Journal of Medical Genetics, 2010

Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females.

Depienne C et al.

Plos Genetics, 2009

X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment.

Dibbens LM et al.

Nature Genetics, 2008

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."